One-year prospective nerve conduction study of thalidomide neuropathy in lupus erythematosus: Incidence, coasting effect and drug plasma levels

MLA

Eloisa Bonfa, et al. “One-Year Prospective Nerve Conduction Study of Thalidomide Neuropathy in Lupus Erythematosus: Incidence, Coasting Effect and Drug Plasma Levels.” Lupus, vol. 30, Mar. 2021, pp. 956–64. EBSCOhost, https://doi.org/10.1177/0961203321998433.

APA

Eloisa Bonfa, Nadia E. Aikawa, Léonard de Vinci Kanda Kupa, Tatiana do Nascimento Pedrosa, Clovis A. Silva, Emily Figueiredo Neves Yuki, Ricardo Romiti, Marcelo Arnone, Sandra Gofinet Pasoto, Carlos Otto Heise, & Renata Alonso Gadi Soares. (2021). One-year prospective nerve conduction study of thalidomide neuropathy in lupus erythematosus: Incidence, coasting effect and drug plasma levels. Lupus, 30, 956–964. https://doi.org/10.1177/0961203321998433

Chicago

Eloisa Bonfa, Nadia E. Aikawa, Léonard de Vinci Kanda Kupa, Tatiana do Nascimento Pedrosa, Clovis A. Silva, Emily Figueiredo Neves Yuki, Ricardo Romiti, et al. 2021. “One-Year Prospective Nerve Conduction Study of Thalidomide Neuropathy in Lupus Erythematosus: Incidence, Coasting Effect and Drug Plasma Levels.” Lupus 30 (March): 956–64. doi:10.1177/0961203321998433.